Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome
Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome
复制标题
DOI:
10.1210/jc.2005-2430
复制
发表时间:
2006-04-01
影响因子:
5.8
通讯作者:
Go, AS
中科院分区:
文献类型:
--
作者:
Lo, JC;Feigenbaum, SL;Go, AS
Context: Polycystic ovary syndrome ( PCOS) is associated with menstrual and reproductive abnormalities, insulin resistance, and obesity.Objective: The objective of this study was to determine the prevalence of diagnosed PCOS and its association with cardiovascular risk factors.Setting: The study is set in an integrated health care delivery system in northern California.Patients: A total of 11,035 women with PCOS were identified by one or more outpatient diagnoses of PCOS using health plan databases. An age-matched sample of women without PCOS was also selected.Outcome Measures: Prevalence of PCOS and targeted cardiovascular risk factors [ hypertension, dyslipidemia, diabetes mellitus, and body mass index (BMI)] were measured.Results: During 2002 - 2004, the prevalence of diagnosed PCOS among female members aged 25 - 34 yr was 2.6% (95% confidence interval 1.6 - 1.7%). Women with diagnosed PCOS were more likely than those without PCOS to be obese [BMI >= 30 mg/m(2); odds ratio ( OR) 4.21, 3.96 - 4.47]. Furthermore, PCOS was associated with diabetes ( OR 2.45, confidence interval 2.16 - 2.79), hypertension ( OR 1.41, 1.31 - 1.51) and known dyslipidemia ( OR 1.53, 1.39 - 1.68), even after adjusting for BMI and known confounders. Among women with PCOS, compared with whites, Blacks and Hispanics were more likely and Asians less likely to be obese; Asians and Hispanics were more likely to have diabetes; and Blacks were more likely and Hispanics less likely to have hypertension.Conclusions: Within a large, community-based population receiving health care, diagnosed PCOS was highly prevalent and associated with a much higher frequency of cardiovascular risk factors that varied by race/ethnicity. Our prevalence estimates likely underestimate the true prevalence of PCOS. Further studies are needed to explore racial/ethnic differences and the extent to which PCOS contributes to future cardiovascular risk.